Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000127867 | SCV000171450 | benign | not specified | 2014-03-12 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Prevention |
RCV000127867 | SCV000311099 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Center for Pediatric Genomic Medicine, |
RCV000421847 | SCV000511686 | benign | not provided | 2017-01-12 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001080699 | SCV000557614 | benign | Progressive myoclonic epilepsy | 2025-01-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002312924 | SCV000847526 | benign | Inborn genetic diseases | 2018-10-19 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |